Researchers Achieve On-Demand Precision Elimination of Target Cells Through a New CRISPR System

In the fields of life sciences and medicine, scientists have long dreamed of possessing a kind of “smart weapon” capable of precisely identifying and eliminating cells from complex environments based on their unique genetic “fingerprints” or transcriptional states. Whether used to destroy cancer cells, remove pathogen-infected cells, or shape specific cell populations, such a technology would represent a revolutionary breakthrough. However, existing approaches such as small-molecule drugs and antibodies often struggle to address complex genetic mutations or changes in non-coding RNAs.

In recent years, CRISPR technology, often referred to as “genetic scissors”, has brought new hope. However, its core tools, such as Cas9, are mainly used for gene editing in eukaryotic cells and are difficult to apply directly for efficient and specific killing of target cells. This is because cells can effectively repair the DNA breaks caused by Cas9. Scientists have therefore urgently needed a new system that can function in eukaryotic cells like a “smart bomb,” triggered by specific RNA signals to carry out cell-elimination commands.

Recently, a collaborative team including Yang Liu from the University of Utah published a research paper online in Nature titled “RNA-triggered cell killing with CRISPR-Cas12a2”. The study successfully engineered a novel CRISPR nuclease called Cas12a2 into a “programmable cell eliminator” suitable for use in eukaryotic cells.

Unlike Cas9, Cas12a2 has a unique feature: when it recognizes a target RNA that perfectly matches its guide RNA (gRNA), it rapidly activates its internal “switch”, shifting from a “standby” state to an “attack” state. Once activated, Cas12a2 releases indiscriminate, nonspecific DNA-cutting activity, triggering widespread DNA double-strand breaks inside the cell nucleus.

In the study, scientists expressed the Cas12a2 protein in human cells and yeast cells. When guide RNAs targeting specific mRNAs were present in the cells, Cas12a2 became activated as soon as it recognized and matched the target RNA signal. The resulting DNA damage acted like a “bomb” detonating inside the cell, making the cell unable to survive and thereby achieving precise elimination.

The research team demonstrated the strong power and high specificity of this platform. They successfully programmed the Cas12a2 system for several applications:

1. Eliminating pathogen-infected cells: By targeting specific mRNAs from human papillomavirus (HPV), the system successfully cleared HPV-infected cells, providing a new strategy for eliminating viral infections.
2. Purifying gene-edited cell populations: In gene-editing experiments, the system can specifically eliminate “wild-type” cells that were not successfully edited, thereby efficiently enriching the population of edited cells and improving experimental efficiency.
3. Targeting oncogenic mutations: By designing gRNAs that target a common cancer-driving point mutation in the KRAS gene, G12V, the Cas12a2 system was able to specifically kill cancer cells carrying the mutation while sparing normal healthy cells, demonstrating its great potential in precision cancer therapy.

Figure 1. Cas12a2 enables enrichment of gene-edited cells. (Scholz P, et al., 2026)

High Specificity and Broad Prospects

Crucially, the system showed extremely high fidelity. The study confirmed that Cas12a2 activation and cell killing are triggered only when the guide RNA perfectly matches the target RNA, with almost no observed off-target damage. This provides an important foundation for the safety of its future applications.

This research breaks through a major bottleneck of existing CRISPR technologies, which have been unable to directly and efficiently perform programmable cell elimination in eukaryotic cells. The Cas12a2 system functions like a “transcript-activated cell-killing switch”, greatly expanding the range of targetable cellular conditions. In the future, it may be developed into a next-generation tool for gene and cell therapy, used to treat cancer and viral infectious diseases, or serve as a powerful research tool for studying cell function. This work opens a new door toward truly “on-demand” cell manipulation.